tadalafil has been researched along with Renal Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altunkaş, F; Çelik, A; Ceyhan, K; Kadı, H; Karayakalı, M; Koç, F; Köseoğlu, RD; Önalan, O; Özbek, K; Söğüt, E | 1 |
| Abassi, Z; Armaly, Z | 1 |
| Abassi, Z; Abu-Saleh, N; Armaly, Z; Aronson, D; Assady, S; Awad, H; Bishara, B; Ghrayeb, N; Goltsman, I; Haddad, E; Haddad, S; Khamaysi, I | 1 |
3 other study(ies) available for tadalafil and Renal Insufficiency
| Article | Year |
|---|---|
The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.
Topics: Administration, Oral; Animals; Contrast Media; Dose-Response Relationship, Drug; Female; Malondialdehyde; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Renal Insufficiency; Tadalafil | 2015 |
Phosphodiesterase-5 inhibitors: emerging nephroprotective drugs.
Topics: Animals; Contrast Media; Female; Phosphodiesterase 5 Inhibitors; Renal Insufficiency; Tadalafil | 2015 |
Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure.
Topics: Animals; Carbolines; Cardio-Renal Syndrome; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Intra-Abdominal Hypertension; Kidney; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renal Plasma Flow; Tadalafil | 2012 |